510 related articles for article (PubMed ID: 34979899)
1. Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study.
Sampaio Rocha-Filho PA; Albuquerque PM; Carvalho LCLS; Dandara Pereira Gama M; Magalhães JE
J Headache Pain; 2022 Jan; 23(1):2. PubMed ID: 34979899
[TBL] [Abstract][Full Text] [Related]
2. Headache associated with COVID-19: Frequency, characteristics and association with anosmia and ageusia.
Rocha-Filho PAS; Magalhães JE
Cephalalgia; 2020 Nov; 40(13):1443-1451. PubMed ID: 33146035
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological and clinical characteristics of survivors of SARS-COV-2 infection: A descriptive study.
Olavegogeascoechea PA; Gallardo Martinez A; Scapellato JL; Federico A
Medwave; 2022 Oct; 22(9):e2581. PubMed ID: 36283026
[TBL] [Abstract][Full Text] [Related]
4. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
Dixon BE; Wools-Kaloustian K; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
medRxiv; 2020 Oct; ():. PubMed ID: 33106813
[TBL] [Abstract][Full Text] [Related]
5. High Prevalence of Headaches During Covid-19 Infection: A Retrospective Cohort Study.
Poncet-Megemont L; Paris P; Tronchere A; Salazard JP; Pereira B; Dallel R; Aumeran C; Beytout J; Jacomet C; Laurichesse H; Lesens O; Mrozek N; Vidal M; Moisset X
Headache; 2020 Nov; 60(10):2578-2582. PubMed ID: 32757419
[TBL] [Abstract][Full Text] [Related]
6. New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection.
Patel A; Charani E; Ariyanayagam D; Abdulaal A; Denny SJ; Mughal N; Moore LSP
Clin Microbiol Infect; 2020 Sep; 26(9):1236-1241. PubMed ID: 32502645
[TBL] [Abstract][Full Text] [Related]
7. Neurological symptoms and comorbidity profile of hospitalized patients with COVID-19.
Cremaschi RC; Bahi CAS; Paola AAV; Arakaki JSO; Ferreira PRA; Bellei NCJ; Borges V; Coelho FMS
Arq Neuropsiquiatr; 2023 Feb; 81(2):146-154. PubMed ID: 36948200
[TBL] [Abstract][Full Text] [Related]
8. Frequency and burden of neurological manifestations upon hospital presentation in COVID-19 patients: Findings from a large Brazilian cohort.
Marcolino MS; Anschau F; Kopittke L; Pires MC; Barbosa IG; Pereira DN; Ramos LEF; Assunção LFI; Costa ASM; Nogueira MCA; Duani H; Martins KPMP; Moreira LB; Silva CTCAD; Oliveira NR; Ziegelmann PK; Guimarães-Júnior MH; Lima MOSS; Aguiar RLO; Menezes LSM; Oliveira TF; Souza MD; Farace BL; Cimini CCR; Maurílio AO; Guimarães SMM; Araújo SF; Nascimento GF; Silveira DV; Ruschel KB; Oliveira TC; Schwarzbold AV; Nasi LA; Floriani MA; Santos VBD; Ramos CM; Alvarenga JC; Scotton ALBA; Manenti ERF; Crestani GP; Batista JDL; Ponce D; Machado-Rugolo J; Bezerra AFB; Martelli PJL; Vianna HR; Castro LC; Medeiros CRG; Vietta GG; Pereira EC; Chatkin JM; Godoy MF; Delfino-Pereira P; Teixeira AL
J Neurol Sci; 2022 Dec; 443():120485. PubMed ID: 36375382
[TBL] [Abstract][Full Text] [Related]
9. Headache characteristics in COVID-19 pandemic-a survey study.
Uygun Ö; Ertaş M; Ekizoğlu E; Bolay H; Özge A; Kocasoy Orhan E; Çağatay AA; Baykan B
J Headache Pain; 2020 Oct; 21(1):121. PubMed ID: 33050880
[TBL] [Abstract][Full Text] [Related]
10. Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study.
Sudre CH; Keshet A; Graham MS; Joshi AD; Shilo S; Rossman H; Murray B; Molteni E; Klaser K; Canas LD; Antonelli M; Nguyen LH; Drew DA; Modat M; Pujol JC; Ganesh S; Wolf J; Meir T; Chan AT; Steves CJ; Spector TD; Brownstein JS; Segal E; Ourselin S; Astley CM
Lancet Digit Health; 2021 Sep; 3(9):e577-e586. PubMed ID: 34305035
[TBL] [Abstract][Full Text] [Related]
11. The importance of anosmia, ageusia and age in community presentation of symptomatic and asymptomatic SARS-CoV-2 infection in Louisiana, USA; a cross-sectional prevalence study.
Feehan AK; Fort D; Velasco C; Burton JH; Garcia-Diaz J; Price-Haywood EG; Sapp E; Pevey D; Seoane L
Clin Microbiol Infect; 2021 Apr; 27(4):633.e9-633.e16. PubMed ID: 33421576
[TBL] [Abstract][Full Text] [Related]
12. Investigation on the Factors Associated with the Persistence of Anosmia and Ageusia in Saudi COVID-19 Patients.
Algahtani SN; Alzarroug AF; Alghamdi HK; Algahtani HK; Alsywina NB; Bin Abdulrahman KA
Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162068
[TBL] [Abstract][Full Text] [Related]
13. Follow-up of adults with noncritical COVID-19 two months after symptom onset.
Carvalho-Schneider C; Laurent E; Lemaignen A; Beaufils E; Bourbao-Tournois C; Laribi S; Flament T; Ferreira-Maldent N; Bruyère F; Stefic K; Gaudy-Graffin C; Grammatico-Guillon L; Bernard L
Clin Microbiol Infect; 2021 Feb; 27(2):258-263. PubMed ID: 33031948
[TBL] [Abstract][Full Text] [Related]
14. Neurological manifestations as prognostic factors in COVID-19: a retrospective cohort study.
Sampaio Rocha-Filho PA; Magalhães JE; Fernandes Silva D; Carvalho Soares M; Marenga Arruda Buarque L; Dandara Pereira Gama M; Oliveira FAA
Acta Neurol Belg; 2022 Jun; 122(3):725-733. PubMed ID: 35060095
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Symptoms after Mild Coronavirus Disease in Healthy Healthcare Professionals: A 12-Month Prospective Cohort Study.
da Costa E Silva GR; Moura WÉA; Dos Santos KC; Gomes DO; Bandeira GN; Guimarães RA; Rosso CFW; Bazilio GS; Leite VRMC; Caetano KAA; Carneiro MADS; Teles SA
Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674238
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of symptoms for pediatric SARS-CoV-2 infection in a primary care setting.
Weng CH; Butt WWW; Brooks MB; Clarke C; Jenkins HE; Holland SD; Chiang SS
PLoS One; 2021; 16(12):e0249980. PubMed ID: 34898635
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of anosmia among COVID-19 patients in Taif City, Kingdom of Saudi Arabia.
Mubaraki AA; Alrbaiai GT; Sibyani AK; Alhulayfi RM; Alzaidi RS; Almalki HS
Saudi Med J; 2021 Jan; 42(1):38-43. PubMed ID: 33399169
[TBL] [Abstract][Full Text] [Related]
18. Headache as a Cardinal Symptom of Coronavirus Disease 2019: A Cross-Sectional Study.
Membrilla JA; de Lorenzo Í; Sastre M; Díaz de Terán J
Headache; 2020 Nov; 60(10):2176-2191. PubMed ID: 32989732
[TBL] [Abstract][Full Text] [Related]
19. Neurological features and outcome in COVID-19: dementia can predict severe disease.
Ghaffari M; Ansari H; Beladimoghadam N; Aghamiri SH; Haghighi M; Nabavi M; Mansouri B; Mehrpour M; Assarzadegan F; Hesami O; Sedaghat M; Farahbakhsh M; Lima BS
J Neurovirol; 2021 Feb; 27(1):86-93. PubMed ID: 33417193
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 infection in children and adolescents: a Brazilian experience.
Santos AORD; Lucarevschi BR; Bajerl MH; Pires LO; Ubriaco DC; Nascimento LFC
Rev Paul Pediatr; 2022; 40():e2021172. PubMed ID: 35544908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
